Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 100

Sort by

Sort Order Select

Journal Articles

Blocking Protein Secretion with Novel Small Molecule Inhibitors of Sec61 Represents a Potential Treatment Strategy Against Hematologic Malignancies

Eric Lowe, BS, Andrea R Fan, PhD, Jing Jiang, Henry W. B. Johnson, PhD, Christopher J. Kirk, PhD, Dustin McMinn, PhD, Tony Muchamuel, MS, Yu Qian, PhD, Brian B. Tuch, PhD

Blood (2019) 134 (Supplement_1): 408.

https://doi.org/10.1182/blood-2019-123782

Published: 2019

Journal Articles

Blood Cell Fate Decisions: Insights from Single-cell RNA-seq

Merav Socolovsky, MBBS, PhD

Blood (2019) 134 (Supplement_1): SCI-20.

https://doi.org/10.1182/blood-2019-121106

Published: 2019

Journal Articles

Gene Editing of BTK in Acute Myeloid Leukaemia Using CRISPR-Cas9

Melanie Maerken, MS, BSc, David MacEwan, PhD, Nicholas Harper, PhD, Joseph R Slupsky, PhD, Adam Linley, PhD

Blood (2018) 132 (Supplement 1): 3952.

https://doi.org/10.1182/blood-2018-99-113804

Published: 2018

Journal Articles

RAS-MPAK Pathway Signaling in Health and Disease

Qing Li, MD PhD

Blood (2018) 132 (Supplement 1): SCI-40.

https://doi.org/10.1182/blood-2018-99-109378

Published: 2018

Journal Articles

Impact of Eltrombopag on Clonal Evolution in Refractory Aplastic Anemia

Bhumika J. Patel, MD, Shimoli Vipul Barot, MD, Bartlomiej P. Przychodzen, Teodora Kuzmanovic, BA, Michael Clemente, MS, Cassandra M. Hirsch, Valeria Visconte, PhD, Roy Souaid, MD, Marissa Versalle, Sarah S Lee, MD, Tomas Radivoyevitch, Metis Haspiek, Swapna Thota, MD, Aziz Nazha, Matt Kalaycio, MD, Anjali S. Advani, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 3869.

https://doi.org/10.1182/blood-2018-99-120330

Published: 2018

Journal Articles

Acute Myeloid Leukemia (AML) with Somatic Mutations in PTPN11 Is Associated with Treatment Resistance and Poor Overall Survival

Justin D. Kaner, MD, Nuria Mencia-Trinchant, PhD, Ariel Schaap, MD, Gail J. Roboz, MD, Sangmin Lee, MD, Pinkal Desai, MD MPH, Michael Samuel, MD, Spencer Krichevsky, BS, Idongessit Udoyen, Duane C. Hassane, PhD, Monica L. Guzman, PhD, Ellen K. Ritchie, MD

Blood (2018) 132 (Supplement 1): 2760.

https://doi.org/10.1182/blood-2018-99-110319

Published: 2018

Journal Articles

Grb10 Is a Tumor Suppressor in Human Acute Myeloid Leukemia

Wanxing Chai-Ho, MD, Martina M Roos, PhDPharmD, Michelle Li, Pang Amara, Yurun Zhang, Tiancheng Fang, Christina Termini, PhDBS, John P Chute, MD

Blood (2018) 132 (Supplement 1): 1344.

https://doi.org/10.1182/blood-2018-99-110844

Published: 2018

Journal Articles

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

Maro N. Ohanian, DO, Tara L Lin, MD, Ellen K. Ritchie, MD, Michael Craig, MD, Apurv Agrawal, MD, Kathleen G. Halka, MD, Vinit Karur, MD, Naveen Pemmaraju, MD, Gautam Borthakur, MD, Sarah Aminov, Miranda Lim, BSN, Sherry A. Pierce, BSN, BA, Natalie Sacarakis, Stacy Minor, Ana Tari Ashizawa, PhD, William Hahne, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Gail J. Roboz, MD

Blood (2018) 132 (Supplement 1): 1387.

https://doi.org/10.1182/blood-2018-99-113693

Published: 2018

Journal Articles

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Rehan Ansari, MD, Elva Nora Osuna Salazar, MD, Nabeel Sarhill, MD, Laura E Garcia, MD, James Hanley, MD

Blood (2018) 132 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2018-99-118271

Published: 2018

Journal Articles

Divergent Evolutionary Trajectories of Erk- and Stat5-Activating Lesions in Acute Lymphoblastic Leukemia

Lai N Chan, Seyedmehdi Shojaee, PhD, Christian Hurtz, PhD, Franziska Auer, PhD, Zhengshan Chen, MDPhD, Kadriye Nehir Cosgun, PhD, Huimin Geng, PhD, Teresa Sadras, PhD, Deborah L White, PhD, Markus Muschen, MD

Blood (2018) 132 (Supplement 1): 568.

https://doi.org/10.1182/blood-2018-99-115536

Published: 2018

Journal Articles

PI3Kinase Inactivation through Combined Loss of Catalytic Subunits p110α, p110β and p110δ Derails Hematopoietic Homeostasis

Lakshmi Reddy Palam, PhD, Raghuveer Mali, PhD, Baskar Ramdas, PhD, Bart Vanhaesebroeck, PhD, Reuben Kapur, PhD

Blood (2017) 130 (Supplement 1): 3754.

https://doi.org/10.1182/blood.V130.Suppl_1.3754.3754

Published: 2017

Journal Articles

Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM

Blood (2017) 130 (Supplement 1): 742.

https://doi.org/10.1182/blood.V130.Suppl_1.742.742

Published: 2017

Journal Articles

Mechanism of Escape from LNK Negative Regulation: Constitutively Active JAK2V617F Retains Lysine63-Ubiquitin

Jeffrey Patterson-Fortin, MD PhD, Jerry L. Spivak, MD, Amy S. Duffield, MD PhD, Donna Marie Williams, PhD, Ophelia Rogers, Zhizhuang Joe Zhao, PhD, Alison R. Moliterno, MD

Blood (2017) 130 (Supplement 1): 2931.

https://doi.org/10.1182/blood.V130.Suppl_1.2931.2931

Published: 2017

Journal Articles

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: A Phase 1 Trial

Michael Rosenzweig, MD, Joycelynne M. Palmer, PhD, Ni-Chun Tsai, MS, Ralf Buettner, PhD, Lupe Duarte, Myo Htut, Chatchada Karanes, Nitya Nathwani, Flavia Pichiorri, PhD, Firoozeh Sahebi, George Somlo, Tim Synold, PhD, Xiwei Wu, PhD, Amrita Krishnan, MD, Stephen J. Forman, MD FACP, Steven T. Rosen, MD

Blood (2017) 130 (Supplement 1): 3144.

https://doi.org/10.1182/blood.V130.Suppl_1.3144.3144

Published: 2017

Journal Articles

BP1001, a Novel Therapeutic for Chronic Myelogenous Leukemia

Ana Tari Ashizawa, PhD, Maro Ohanian, DO, Jorge E. Cortes, MD

Blood (2016) 128 (22): 4239.

https://doi.org/10.1182/blood.V128.22.4239.4239

Published: 2016

Journal Articles

Clonal Dynamics of Refractory Aplastic Anemia in Patients Treated with Eltrombopag

Bhumika Patel, MD, Bartlomiej P Przychodzen, MSc, Michael J. Clemente, M.S., Cassandra M. Hirsch, BSc, Caner Saygin, MD, Marissa Versalle, MD, Swapna Thota, MD, Aziz Nazha, MD, Roy Souaid, MD, Valeria Visconte, PhD, Taha Bat, MD, Suresh Kumar Balasubramanian, MD, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 3892.

https://doi.org/10.1182/blood.V128.22.3892.3892

Published: 2016

Journal Articles

Blood ’s 70th anniversary: a rich history

Bob Löwenberg

Blood (2015) 126 (24): 2529–2530.

https://doi.org/10.1182/blood-2015-10-673954

Published: 2015

Journal Articles

Study of the Subclonal Mutations in Primary Diffuse Large B-Cell Lymphoma

Yan Asmann, PhD, Vivekananda Sarangi, MS, Chen Wang, PhD, Matthew J Maurer, MS, Stephen Ansell, MD PhD, Andrew L Feldman, MD, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Anne J. Novak, PhD, Susan L. Slager, PhD, Brian K Link, MD, James Cerhan, MD PhD

Blood (2015) 126 (23): 131.

https://doi.org/10.1182/blood.V126.23.131.131

Published: 2015

Journal Articles

Focal Adhesion Kinase As a Potential Target in AML and MDS

Bing Z Carter, Steven M. Kornblau, MD, Po Yee Mak, MPhil, Hui Yang, MD PhD, Yihua Qiu, MD, Xuejie Jiang, Kevin Coombes, PhD, Nianxiang Zhang, Guillermo Garcia-Manero, MD, Michael Andreeff, MD, PhD

Blood (2015) 126 (23): 3680.

https://doi.org/10.1182/blood.V126.23.3680.3680

Published: 2015

Journal Articles

Impact of Eltrombopag on Expansion of Clones with Somatic Mutations in Refractory Aplastic Anemia

Bhumika J. Patel, Bartlomiej Przychodzen, MSc, Michael J. Clemente, Cassandra M. Hirsch, Tomas Radivoyevitch, PhD, Swapna Thota, MD, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 300.

https://doi.org/10.1182/blood.V126.23.300.300

Published: 2015

NARROW

Blocking Protein Secretion with Novel Small Molecule Inhibitors of Sec61 Represents a Potential Treatment Strategy Against Hematologic Malignancies

Blood Cell Fate Decisions: Insights from Single-cell RNA-seq

Gene Editing of BTK in Acute Myeloid Leukaemia Using CRISPR-Cas9

RAS-MPAK Pathway Signaling in Health and Disease

Impact of Eltrombopag on Clonal Evolution in Refractory Aplastic Anemia

Acute Myeloid Leukemia (AML) with Somatic Mutations in PTPN11 Is Associated with Treatment Resistance and Poor Overall Survival

Grb10 Is a Tumor Suppressor in Human Acute Myeloid Leukemia

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Divergent Evolutionary Trajectories of Erk- and Stat5-Activating Lesions in Acute Lymphoblastic Leukemia

PI3Kinase Inactivation through Combined Loss of Catalytic Subunits p110α, p110β and p110δ Derails Hematopoietic Homeostasis

Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM

Mechanism of Escape from LNK Negative Regulation: Constitutively Active JAK2V617F Retains Lysine63-Ubiquitin

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: A Phase 1 Trial

BP1001, a Novel Therapeutic for Chronic Myelogenous Leukemia

Clonal Dynamics of Refractory Aplastic Anemia in Patients Treated with Eltrombopag

Blood ’s 70th anniversary: a rich history

Study of the Subclonal Mutations in Primary Diffuse Large B-Cell Lymphoma

Focal Adhesion Kinase As a Potential Target in AML and MDS

Impact of Eltrombopag on Expansion of Clones with Somatic Mutations in Refractory Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only